News
Academy
Publications
All Publications
eBooks
Media
Editorial Podcasts
Editorial Videos
Peer Exchange
Practice Academy
Shorts
Sponsored Podcasts
Sponsored Videos
More
Conferences
Conference Coverage
Conference Listing
Columns
All Columns
A Closing Thought
Clinical Trial Insights
View from Brussels
View from Washington
Resources
Advertise
Blogs
Events
Front & Center
Partner Perspectives
White Papers
Events
Webcasts
Event Calendar
Subscribe
My Account
News
Academy
Publications
Media
Conferences
Columns
Resources
Events
Subscribe
Event Calendar
Clinical Operations & Strategy
Decentralized Clinical Trials
Trial Design
Investigative Sites
CRO/Sponsor
Risk-Based Monitoring
Protocol Design
Clinical Trial Supply Chain
Study Start-Up
Early Phase Development
DEI
Industry Initiatives
Diversity Action Plans
Recruitment
Data Management
Analytics
Electronic Data Capture
Real World Evidence
Metrics & Benchmarks
Patient Participation
Integrated Research
CRAACO
Enrollment
Regulatory
Institutional Review Board & Ethics Committee
FDA
EMA
Technology
Artificial Intelligence/Machine Learning
eClinical
mHealth
Choose Specialty
Spotlight -
Conference Coverage
|
Peer Exchange
|
DE&I
|
Editorial Videos
|
Clinical Operations & Strategy
|
Patient Participation
Advertisement
Brenda Reese
Advertisement
Articles by Brenda Reese
"Sponsors: Engage Your CRO Early and Often"
By
Brenda Reese
July 18th 2011
Applied Clinical Trials
Advertisement
Latest Updated Articles
"Sponsors: Engage Your CRO Early and Often"
July 18th 2011
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Lessons from Hundreds of Clinical Trials: AI’s Successes, Gaps, and Opportunities
2
The Execution Gap: Why Clinical Trial Infrastructure Has to Be Built Before AI Can Deliver
3
The Evolution of Preclinical CRO Strategic Partnerships: From Transactional Services to Value-Driven Ecosystems in 2026
4
Benchmarking Study Finds Clinical Trial Performance Is Shaped by Operating Model Design, Not Sourcing Strategy
5
Operationalizing the Patient Voice: Converging U.S., EU, and UK Requirements and the Role of Real-World Patient-Reported Data